Methodological issues with the risk of relapse study in patients with multiple sclerosis after yellow fever vaccination
Arch Neurol
.
2012 Jan;69(1):144; author reply 144-5.
doi: 10.1001/archneurol.2011.1519.
Authors
Vitali Pool
,
Daniel M Gordon
,
Michael Decker
PMID:
22232361
DOI:
10.1001/archneurol.2011.1519
No abstract available
Publication types
Comment
MeSH terms
Female
Humans
Male
Multiple Sclerosis / immunology*
Yellow Fever / prevention & control*
Yellow Fever Vaccine / immunology*
Substances
Yellow Fever Vaccine